Feb 21, 2022
Valuation of Cannabis Co’s w/ CPA Josephine Giordano
- BRT S03 EP08 (107) 2-20-2022
Things We Learned This Week
Giordano, CPA, ABV, CFF, CFE, CBA, ASA, CDBV, CIRA, CICA,
Director in the Financial Forensics and Business Valuation Services Group
National Cannabis Practice Leader
Josephine Giordano is a Director in the Financial Forensics and Valuation Services Group and National Cannabis Practice Leader at BeachFleischman PC. Ms. Giordano’s extensive experience includes the areas of internal audit, banking, regulatory compliance, fraud investigation, forensic accounting, public accounting/tax, business valuations, bankruptcy & restructuring, turnaround management, expert witness, court-appointed receiverships, and special master and compliance monitoring appointments. She also holds an MBA in corporate finance. She has been consulting and doing accounting for over 25 years, with the last five, working in Cannabis.
Adult use was legalized in 11/2020, and started ops 2/2021
Dept of Economic Research (AZ Dept of Rev)
$1.2 billion in sales thru 11/2021, Adult total sales $520 million
Medical (2021) - total sales $700 million; sales tax 459 million
Sales tax $44 million, Excise tax $93 million
2022 expectations to be bigger
Valuation of cannabis business - new sector, does not have comparison data of 5+ years business sales.
Compare current industry numbers and do estimates, guesstimate – especially if business not profitable. Challenge to determine FMV (Fair Market Value)
Cannabis in AZ – buy board seats to control license, do not buy license
Large MSO – multi state operators - example: CureLeaf.
Risk factors – Risk vs. ROI (Return On Investment)
Company specific risk- regulations, banking and tax laws in cannabis.
Tax risk – 280 E, cannabis is Fed. Illegal, so limited deductions, equals high federal tax, affects cash flow.
Regulatory risk – Federal government can shut down.
Apply risk component to income stream, higher risk will lower value
Income approach and DCF model, discount cash flow vs future sales projections.
If federal changes regulations and laws – then expense write off of tax, and other banking and legal expenses will be lower.
Risk – with staff and Keyman
Regardless of risk – MSO paying premium for access to license MSO knows risk and costs.
Valuation numbers do not entirely make sense-
CureLeaf deal late 2021, $12 million cash plus $1 million stock.
Earnings and EBITDA are standard metrics that cannabis does not use vs standard co. like industrial (plumbing, A/C)
Lending in cannabis deals – hard to get money, Cannabis could not PPP loans
Banking regulations – cash business and has risk with theft and fraud. Can only use state banks vs national like Chase or B of A.
Access to capital is tricky, how to get money to buy out partner.
Canadian market doesn’t have good comps or data, different accounting rules vs. US.
Banks want collateral, like real estate. Do not want to lend on license. Hard to determine the future earnings & cash. Private money will do lending with high interest rates of 10%.
Barriers to entry – need cash money to get into industry, lots of cash, but lots of sales potential
Legalization on Federal level – affects tax, banking, lending, expenses, cash flow.
Operators – have to be good at business, operations, finances.
Business Sale – due diligence, must be organized internally, especially financial info
Investors want to see good books and efficient operation
State regulators can strip or shut down a license for non-compliance.
Cannabis Topic: https://brt-show.libsyn.com/category/Cannabis-Hemp-Marijuana
Thanks for Listening.
Please Subscribe to the BRT Podcast.
Business Roundtable with Matt Battaglia
The show where Entrepreneurs, High Level Executives, Business Owners, and Investors come to share insight and ideas about the future of business. BRT 2.0 looks at the new trends in business, and how classic industries are evolving.
Common Topics Discussed: Business, Entrepreneurship, Investing, Stocks, Cannabis, Tech, Blockchain / Crypto, Real Estate, Legal, Sales, Charity, and more…
BRT Podcast Home Page: https://brt-show.libsyn.com/
‘Best Of’ BRT Podcast: Click Here
BRT Podcast on Google: Click Here
BRT Podcast on Spotify: Click Here
KFNX Info: https://1100kfnx.com/weekend-featured-shows/
Disclaimer: The views and opinions expressed in this program are those of the Hosts, Guests and Speakers, and do not necessarily reflect the views or positions of any entities they represent (or affiliates, members, managers, employees or partners), or any Station, Podcast Platform, Website or Social Media that this show may air on. All information provided is for educational and entertainment purposes. Nothing said on this program should be considered advice or recommendations in: business, legal, real estate, crypto, tax accounting, investment, etc. Always seek the advice of a professional in all business ventures, including but not limited to: investments, tax, loans, legal, accounting, real estate, crypto, contracts, sales, marketing, other business arrangements, etc.